Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Pharmaceutical Sciences is a dynamic and interdisciplinary field that aims to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology to understand how to optimize delivery of drugs to the body and translate this integrated understanding into new and improved therapies against human disease.

Pharmaceutical Scientists give papers that describe revolutionary research spanning the complete spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology merchandise together with genes, peptides, proteins and vaccines, and genetically engineered cells are a fundamental part of papers posted here. The current emphasis of the journal consists of the following areas: preformulation; drug shipping and focused on; components design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others.


drug goes from being an idea in the lab to something that a doctor prescribes. To do this, it must go through a long development and approval process. During this process, researchers make sure the drug is safe for people to take and effectively treats cancer. This process often takes many years and significant resources. But the actual amount of time and money needed depends on the drug.


  • Track 2-1Pre-clinical research
  • Track 2-2Clinical research
  • Track 2-3Post-clinical research

Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active the drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form.


Formulation development studies determine the optimal dosage form, composition and manufacturing route is a fundamental part of pharmaceutical product development. Getting pharmaceutical formulation development right helps to optimise drug delivery performance and product stability. Complex dosage forms, in particular, inhaled and nasal products can present unique challenges for controlling the performance of the drug product and impact bioavailability. Solid, semi-solid and liquid formulations are developed using pre-formulation data to design prototype formulations and processes. The formulation development centre also has its own validated stability chambers to conduct lab stability tests to support selection of a suitable formulation and manufacturing process


Drug delivery is the process of administering the drug or pharmaceutical product, in order to achieve the desired therapeutic effect. The method by which drug delivered is important, as it has a significant effect on its efficacy. Novel drug delivery system involves various approaches like medical devices or drug-device combination products. Novel drug delivery system (NDDS) involves combining polymer science, pharmaceutics and molecular biology.

  To minimize drug degradation and loss to prevent harmful side-effects and to increase drug bioavailability and the fraction of the drug accumulated in the required zone, various drug delivery and drug targeting systems are currently under development. Among drug carriers one can name soluble polymers,micro particles made of insoluble or biodegradable natural and synthetic polymers, microcapsules, cells, cell ghosts, lipoproteins, liposomes, and micelles. The carriers can be made slowly degradable, stimuli-reactive (e.g., pH- or temperature-sensitive), and even targeted (e.g., by conjugating them with specific antibodies against certain characteristic components of the area of interest). Targeting is the ability to direct the drug-loaded system to the site of interest. Two major mechanisms can be distinguished for addressing the desired sites for drug release: (i) passive (ii) active targeting.

Drug design, often referred to as rational drug design or simply rational design is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in the therapeutic benefit to the patient.

Medication conveyance characterizes as the best approach to take pharmaceutical from the diverse course of ogranization show in a human body and inaddition creature. At the point when the medication is goneinto human or creature body begins to demonstrate some helpful impact, which mends our body, experience the ill effects ofparticular infection or sick. Medication will begin go from pharmacokinetics frame work which contain adsorption, digestion, dissemination and discharge andafter that goes into the circulatory framework, wherethe particular medication reach to particular receptors and tie withthe receptors, which begin recuperate to body. Medication conveyance has donefrom various course, e.g.; oral course, intravenous course, intramuscularcourse, transdermal patches, intraocular course,intra-peritoneal, suppositories, and so on targeted delivery. Nanoparticle formulation, Nanomedicine delivery and inhalation aerosols, Self-emulsifying drug delivery system, Oral and parental drug delivery.

  • Track 7-1Nanomedicine And Biomedical Applications
  • Track 7-2Novel Drug Delivery System
  • Track 7-3Nanoparticulate Drug Delivery Systems
  • Track 7-4Nanoparticle Fabrication
  • Track 7-5Big Data To Help Nanotechnology
  • Track 7-6Clinical Translation Of Nanotechnology
  • Track 7-7Clinical Translation Of Nanotechnology
  • Track 7-8Nanoparticles For Immuno-Oncology And Screening.

All pharmaceutical products are formulated to specific dosage forms for drugs to be effectively delivered to patients. Typical pharmaceutical dosage forms include oral tablets, capsules, solutions, suspensions, topical ointments, gels, and solutions, and injections for intravenous (IV), intramuscular (IM), or subcutaneous (SC) administration. In addition, various drug delivery systems have been developed for transdermal, intranasal, and pulmonary deliveries. Different dosage forms require different pharmaceutical technologies and usually present different technical challenges for formulation development.

Because of the complex technical challenges scientists encounter during formulation development, it is important to use an effective methodology. Design of experiments and statistical analysis have been applied widely to formulation development, and are useful in process optimization and process validation. The major advantage of using Design of experiments to develop formulations for pharmaceutical products is that it allows all potential factors to be evaluated simultaneously, systematically, and quickly. Using Design of experiments, one can evaluate the effect of each formulation factor on each response (and possibly the interaction effects between factors) and identify the critical factors based on statistical analysis. Once the critical factors have been identified, the optimal formulation can be defined by using proper Design of experiments to optimize the levels of all critical factors. The manufacturing process also can be developed and optimized in the same fashion. When the formulation and manufacturing process of a pharmaceutical product are optimized by a systematic approach using Design of experiments, scale-up and process validation can be very efficient because of the robustness of the formulation and manufacturing process.


Industrial Pharmacy also plays a crucial role in any drug discovery. To any novel drug discovery the industrial approach is very important to get massive commercial application. Few things which have to be considered by industries to provide a safe and cost affective medicine to the patients like Supply chain, Waste management, Product management, Post- marketing surveillance, , Good manufacturing practices and Marketing.

The U.S. pharmaceutical market is the world’s most important national market. Together with Canada and Mexico, it represents the largest continental pharma market worldwide.

  • Track 9-1Waste management
  • Track 9-2Product management
  • Track 9-3Post- marketing surveillance
  • Track 9-4Good manufacturing practices
  • Track 9-5Pharmaceutical Marketing

The scientific importance of character pharmacokinetic and pharmacodynamic variations amongst enantiomers is mentioned. A quantity of mechanisms within the frame can be stereoselective, among them first-pass metabolism, metabolic clearance, renal clearance, and protein and tissue binding. Differences in first-skip metabolism may also purpose differences within the ratio of plasma concentrations of enantiomers whilst a drug is given by way of the intravenous route in comparison with the oral direction. Stereoisomers of a drug may be metabolized via two exclusive enzyme structures, ensuing in distinct costs of metabolic clearance; age and intercourse might also have an effect on the rates of enzymatic metabolism of stereoisomers. Substantial variations inside the protein binding of  enantiomers may additionally result in a distinction of their glomerular filtration costs. Two enantiomers may additionally bind in another way to protein or to different tissue receptor web sites, resulting in variations in drug results or distribution. There are no simple solutions to questions regarding the pharmacokinetics of racemic drug combinations and unmarried enantiomers. The homes of enantiomers in every drug will must be evaluated for his or her pharmacokinetic disposition and their healing index.

Process validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process is capable of consistently delivering quality products.


The field of toxicology has changed significantly over the last decade, toxicology experts are stepping away from traditional techniques and are shifting towards novel methods for assessing toxicity. More specifically, they are embracing the advancing areas of cell culture, molecular biology and use of computer modelling for toxicological outcome prediction.

Toxicology is the scientific study of adverse effects that occur in living organisms due to chemicals. It involves observing and reporting symptoms, mechanisms, detection and treatments of toxic substances, in particular relation to the poisoning of humans.

It includes environmental agents and chemical compounds found in nature, as well as pharmaceutical compounds that are synthesized for medical use by humans. These substances may produce toxic effects in living organisms including disturbance in growth patterns, discomfort, disease and death.

  • Track 12-1Aquatic toxicology
  • Track 12-2Chemical toxicology
  • Track 12-3Clinical toxicology
  • Track 12-4Ecotoxicology
  • Track 12-5Environmental toxicology
  • Track 12-6Forensic toxicology
  • Track 12-7Medical toxicology
  • Track 12-8Occupational toxicology
  • Track 12-9Regulatory toxicology

Pharmaceutical biotechnology has emerged as one of the major disciplines for drug discovery and development. Today the shape and vision of pharmaceutical aspects and challenges have completely changed, and the prefix "pharma" can also be accepted as a synonym for integrated life science approaches, ranging from genetics to molecular biology to diagnostics, with the common goal of delivering the best drug to the patient by biotechnological techniques.


Biopharmaceutics and pharmacokinetics are pharmaceutical disciplines useful to improve the outcome of drug therapies, assist drug product development, and establish pharmacokinetics-pharmacodynamics models and in vitro-in vivo correlations. Here, we introduce some essential lexicon that will be used throughout this volume and discuss the relationship between drug exposure and pharmacological response, in the framework of the free drug theory/hypothesis.


Vaccines not only afford the best protection against infectious disease but can serve as strong deterrence factors as well. From a bioterrorist perspective, vaccine-resistant agents are more difficult to engineer than drug-resistant agents. But the potential market has been too small and uncertain to encourage the vaccine industry to make large investments in research, development, and manufacturing of new products. This is alarming considering the eight to ten years often needed to develop a new vaccine, compared to only two to three years to develop a new bioweapon.


Drug manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others.

Pharmaceutical Packaging can be defined as an economical means of providing presentation, protection, identification information, containment, convenience and compliance for a product during storage, carriage, display and until the product is consumed. Packaging must provide protection against climatic conditions biological, physical and chemical hazards and must be economical. Pharmaceutical marketing is based on product type and geography. The pharmaceutical packaging market is constantly advancing and has experienced annual growth of at least five percent per annum in the past few years as with most other packaged goods, pharmaceuticals need reliable and speedy packaging solutions that deliver a combination of product protection, quality, tamper evidence, patient comfort and security needs.


Pharmaceutical marketing some times called medico marketing or pharma marketing in some countries,it is business of advertising or promoting the sale of pharmaceuticals or drug. It  is characterized as the matter of advancing or publicizing the offer of Pharmaceutical medications. brings issues to light about Treatments for Chronic Diseases. The prime contributing components to be considered in Pharma promoting are developing dangers, express raising costs, changing purchaser needs and fixing controls, internationally.

  • Track 18-1Evolution in Pharma marketing
  • Track 18-2Pharma marketing strategies
  • Track 18-3Importance of Emerging Markets
  • Track 18-4Pharmaceutical products

A drug interaction is a situation in which a substance (usually another drug) affects the activity of a drug when both are administered together. This action can be synergistic (when the drug's effect is increased) or antagonistic (when the drug's effect is decreased) or a new effect can be produced that neither produces on its own. Typically, interactions between drugs come to mind (drug-drug interaction). However, interactions may also exist between drugs and foods (drug-food interactions), as well as drugs and medicinal plants or herbs (drug-plant interactions). People taking antidepressant drugs such as monoamine oxidase inhibitors should not take food containing tyramine as hypertensive crisis may occur (an example of a drug-food interaction). These interactions may occur out of accidental misuse or due to lack of knowledge about the active ingredients involved in the relevant substances.


In pharmaceutical science, certain ethical principles are composed to ensure the patient’s integrity and safety that must be followed by individual involving in pharmaceutical industry. These may include autonomy, justice, beneficence, and non-maleficence. Pharmacy practice is vulnerable to ethical challenges associated with pharmaceutical care, relationship with patient’s cooperation with the healthcare team that needs special code of conducts These codes of conducts include professional code of ethics for pharmacists and ethics guidelines for pharmaceutical importers, pharmaceutical companies, distributors and policy makers.